相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Modular, efficient and constant-memory single-cell RNA-seq preprocessing
Pall Melsted et al.
NATURE BIOTECHNOLOGY (2021)
NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS
Cynthia Louis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Advanced Cell Mapping Visualizations for Single Cell Functional Proteomics Enabling Patient Stratification
Nick Bowman et al.
PROTEOMICS (2020)
Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice
Kawaljit Kaur et al.
CANCERS (2020)
Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells
Lucas Ferrari de Andrade et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Demystifying drop-outs in single-cell UMI data
Tae Hyun Kim et al.
GENOME BIOLOGY (2020)
CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
Andrea Walens et al.
ELIFE (2019)
DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors
Christopher S. McGinnis et al.
CELL SYSTEMS (2019)
Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects
Barbara Bassani et al.
CANCERS (2019)
Killers 2.0: NK cell therapies at the forefront of cancer control
Jonathan J. Hodgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
NK Cell Plasticity in Cancer
Sizhe Liu et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Fast, sensitive and accurate integration of single-cell data with Harmony
Ilya Korsunsky et al.
NATURE METHODS (2019)
Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression
Christoph Hafemeister et al.
GENOME BIOLOGY (2019)
EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data
Aaron T. L. Lun et al.
GENOME BIOLOGY (2019)
Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL
John Rossi et al.
BLOOD (2018)
NKG2D and its ligands in cancer
Payal Dhar et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Andrew Butler et al.
NATURE BIOTECHNOLOGY (2018)
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Lucas Ferrari de Andrade et al.
SCIENCE (2018)
The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands
Jianmin Zuo et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Paradoxical Role of NKG2D in Cancer Immunity
Sam Sheppard et al.
FRONTIERS IN IMMUNOLOGY (2018)
The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer
Marjorie De la Fuente López et al.
TUMOR BIOLOGY (2018)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients
Carolina Hager Ribeiro et al.
ONCOLOGY REPORTS (2016)
The clinical and biological significance of MICA in clear cell renal cell carcinoma patients
Xiang Zhang et al.
TUMOR BIOLOGY (2016)
Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors
Shengjun Lu et al.
CLINICAL CANCER RESEARCH (2015)
Comparative genomics of the NKG2D ligand gene family
Masanori Kasahara et al.
IMMUNOLOGICAL REVIEWS (2015)
Soluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotype
Gang Xiao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
NKG2D Receptor and Its Ligands in Host Defense
Lewis L. Lanier
CANCER IMMUNOLOGY RESEARCH (2015)
MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
Hanbyoul Cho et al.
BMC CANCER (2014)
The Inflammatory Chemokine CCL5 and Cancer Progression
Donatella Aldinucci et al.
MEDIATORS OF INFLAMMATION (2014)
Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells
Giulia Matusali et al.
FASEB JOURNAL (2013)
Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis
Gang Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells
Kamalakannan Rajasekaran et al.
NATURE IMMUNOLOGY (2013)
Effects of MICA Expression on the Prognosis of Advanced Non-Small Cell Lung Cancer and the Efficacy of CIK Therapy
Yu Chen et al.
PLOS ONE (2013)
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
Esther M. de Kruijf et al.
BMC CANCER (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Nicolas F. Delahaye et al.
NATURE MEDICINE (2011)
ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis
Andrea Maul-Pavicic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
An six-amino acid motif in the α3 domain of MICA is the cancer therapeutic target to inhibit shedding
Xuanjun Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis
Kui Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Obstructing Shedding of the Immunostimulatory MHC Class I Chain-Related Gene B Prevents Tumor Formation
Jennifer D. Wu et al.
CLINICAL CANCER RESEARCH (2009)
Oxidative DNA damage in the prostate may predispose men to a higher risk of prostate cancer
Jennifer D. Wu et al.
TRANSLATIONAL ONCOLOGY (2009)
NK cell-activating receptors require PKC-θ for sustained signaling, transcriptional activation, and IFN-γ secretion
Ilaria Tassi et al.
BLOOD (2008)
The killer's kiss: the many functions of NK cell immunological synapses
Konrad Krzewski et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity
Changlin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands
Brett K. Kaiser et al.
NATURE (2007)
Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity
Xi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Opposing roles of NF-κB family members in the regulation of NK cell proliferation and production of IFN-γ
CM Tato et al.
INTERNATIONAL IMMUNOLOGY (2006)
How NKG2D ligands trigger autoimmunity?
Sophie Caillat-Zucman
HUMAN IMMUNOLOGY (2006)
Phospholipase C-γ2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells
A Caraux et al.
BLOOD (2006)
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
DE Oppenheim et al.
NATURE IMMUNOLOGY (2005)
Phospholipase C-γ2 is a critical signaling mediator for murine NK cell activating receptors
I Tassi et al.
JOURNAL OF IMMUNOLOGY (2005)
T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells
MJ Townsend et al.
IMMUNITY (2004)
Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer
JD Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Roles of the NKG2D immunoreceptor and its ligands
DH Raulet
NATURE REVIEWS IMMUNOLOGY (2003)
Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rhe'umatoid arthritis
V Groh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
The role of the NKG2D immunoreceptor in immune cell activation and natural killing
AM Jamieson et al.
IMMUNITY (2002)
Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?
E Vivier et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Regulation of phospholipase C γ isoforms in haematopoietic cells -: Why one, not the other?
JI Wilde et al.
CELLULAR SIGNALLING (2001)
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
A Cerwenka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
A Diefenbach et al.
NATURE (2001)
Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms
F Colucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA
PW Li et al.
NATURE IMMUNOLOGY (2001)
DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells
J Wu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
ZM Sun et al.
NATURE (2000)
A novel transcription factor, T-bet, directs Th1 lineage commitment
SJ Szabo et al.
CELL (2000)
分享论文
